The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 23, 2014

Filed:

Mar. 05, 2013
Applicant:

Vascular Biogenics Ltd., Or Yehuda, IL;

Inventors:

Dror Harats, Ramat Gan, IL;

Shoshana Greenberger, Petach Tikva, IL;

Eyal Breitbart, Hashmonaim, IL;

Assignee:

Vascular Biogenics Ltd., Or Yehuda, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); A61K 48/00 (2006.01); C12N 5/00 (2006.01); C12N 5/02 (2006.01); A61K 38/17 (2006.01); A61K 31/711 (2006.01); A61K 38/19 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
A61K 38/191 (2013.01); A61K 48/0008 (2013.01); A61K 48/00 (2013.01); C12N 2840/20 (2013.01); C12N 2800/108 (2013.01); A61K 38/1793 (2013.01); A61K 31/711 (2013.01); C12N 2830/008 (2013.01); C12N 2830/15 (2013.01); C12N 15/86 (2013.01); A61K 38/177 (2013.01); C12N 2830/85 (2013.01); C12N 2710/10343 (2013.01);
Abstract

A novel nucleic acid construct for down-regulating angiogenesis in a tissue of a subject is provided. The nucleic acid construct includes: (a) a first polynucleotide region encoding a chimeric polypeptide including a ligand binding domain fused to an effector domain of an apoptosis signaling molecule; and (b) a second polynucleotide region encoding a cis acting regulatory element being for directing expression of the chimeric polypeptide in a specific tissue or cell; wherein the ligand binding domain is selected such that it is capable of binding a ligand present in the specific tissue or cell, whereas binding of the ligand to the ligand binding domain activates the effector domain of the apoptosis signaling molecule. Also provided are methods of utilizing this nucleic acid construct for treating diseases characterized by excessive or aberrant neo-vascularization or cell growth.


Find Patent Forward Citations

Loading…